TDO2 and neoplasm: Significant differences between IDO1 expression and regulation have, for example, been observed in human and murine mesenchymal stromal cells (MSCs).123–125 Similar to the case for IDO1, preclinical murine tumour models usually also lack TDO2 expression, distinguishing them from human cancers.